Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Mycosis Fungoides 1

Interventions

mogamulizumab 7Specimen Handling 5Immunoglobulin G 5Disulfides 5Cyclophosphamide 5Biopsy 5pembrolizumab 4fludarabine 4Magnetic Resonance Spectroscopy 4Brentuximab Vedotin 4hypericin 3fludarabine phosphate 3cemiplimab 3Radiotherapy 3Nivolumab 3sodium-iodide symporter 2X-Rays 2Whole-Body Irradiation 2Tacrolimus 2Phototherapy 2Photons 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Busulfan 2talimogene laherparepvec 1ruxolitinib 1romidepsin 1magrolimab 1duvelisib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycosis Fungoides × Amines × 1 year × Clear all
NCT06149247 2025-08-20

HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL

Soligenix

Phase 2 Completed
10 enrolled 7 charts
Lymphoid

Mycosis Fungoides

Data powered by HemOnc (CC BY 4.0) Colophon âš¡